Label: EQUISTRENGTH- pyrantel pamoate paste
- NDC Code(s): 46066-912-01
- Packager: Aspen Veterinary
- Category: OTC ANIMAL DRUG LABEL
- DEA Schedule: None
- Marketing Status: New Animal Drug Application
Updated December 10, 2018
If you are a consumer or patient please visit this version.
Equistrength® Paste (pyrantel pamoate) is a pale yellow to buff paste containing 43.9% w/w pyrantel pamoate in an inert vehicle. Each syringe contains 3.6 grams pyrantel base in 23.6 grams paste. Each milliliter contains 171 milligrams pyrantel base as pyrantel pamoate.
READ ENTIRE DIRECTIONS CAREFULLY BEFORE USING THIS CARTON.
COMPOSITION: Pyrantel pamoate is a compound belonging to a family classifed chemically as tetrahydropyrimidines. It is a yellow, water-insoluble crystalline salt of the tetrahydropyrimidine base and pamoic acid containing 34.7% base activity.
The chemical structure and name are given below:
(E)-1,4,5,6-tetrahydro-1-methyl-2-[2-(2-thienyl)-vinyl]-pyrimidine 4,4' methylenebis [3-hydroxy-2 naphtholate] (1:1)
INDICATIONS & USAGE
INDICATIONS: For the removal and control of mature infections of large strongyles (Strongylus vulgaris, S. edentatus, S. equinus); small strongyles; pinworms (Oxyuris equi); and large roundworms (Parascaris equorum) in horses and ponies. Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism.
DOSAGE & ADMINISTRATION
DOSAGE AND TREATMENT: Equistrength® Paste (pyrantel pamoate) is to be administered as a single oral dose of 3 milligrams pyrantel base per pound of body weight. The syringe has four weight mark increments. Each weight mark indicates the recommended dose for 300 pounds of body weight.
Body Weight Range Quantity mg Pyrantel Base
up to 300 lb 1/4 syringe 900 mg
301 to 600 lb 1/2 syringe 1800 mg
601 to 900 lb 3/4 syringe 2700 mg
901 to 1200 lb 1 full syringe 3600 mg
NOTE: Position ringe-gauge over appropriate mark on plunger.
For maximum control of parasitism, it is recommended that foals (2-8 months of age) be dosed every 4 weeks. To minimize the potential source of infection that the mare may pose to the foal, the mare should be treated 1 month prior to anticipated foaling date followed by re-treatment 10 days to 2 weeks after birth of foal. Horses and ponies over 8 months of age should be routinely dosed every 6 weeks. It is recommended that severely debilitated animals not be treated with this preparation.
ADMINISTRATION: After removing the cap, the paste should be deposited on the dorsum of the tongue. Introduce the nozzle end of the syringe at the corner of the mouth. Direct the syringe backwards and depress the plunger to deposit the paste onto the tongue. Given in this manner, it is unlikely that rejection of the paste will occur. Raising the horse's head sometimes assists in the swallowing process. When only part of the paste has been used, replace the cap on the syringe nozzle.
- SUMMARY OF SAFETY AND EFFECTIVENESS
- PRINCIPAL DISPLAY PANEL
INGREDIENTS AND APPEARANCE
pyrantel pamoate paste
Product Information Product Type OTC ANIMAL DRUG Item Code (Source) NDC:46066-912 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength PYRANTEL PAMOATE (UNII: 81BK194Z5M) (PYRANTEL - UNII:4QIH0N49E7) PYRANTEL 3.6 g in 23.6 g Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:46066-912-01 23.6 g in 1 CARTON Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NADA NADA200350 01/19/2005 Labeler - Aspen Veterinary (627265361) Registrant - Bimeda, Inc. (060492923) Establishment Name Address ID/FEI Business Operations Bimeda-MTC 256232216 manufacture Establishment Name Address ID/FEI Business Operations Moehs 460021629 api manufacture Establishment Name Address ID/FEI Business Operations Minsheng Group Shaoxing Pharmaceutical Co., Ltd. 544607919 api manufacture